(Press-News.org) SAN FRANCISCO (March 11, 2013) — All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
The transcatheter aortic valve replacement (TAVR) system was investigated as an alternative to open-heart surgery for high-risk patients with severe aortic stenosis—narrowing of a main circulatory gateway in the heart that reduces blood flow. This condition affects roughly 300,000 Americans age 75 or older, who often have multiple health issues that make surgery especially risky. Recovery from catheter-based valve replacement typically takes a few days compared with four to eight weeks for open-heart surgery, which may be a benefit in a high-risk patient population.
The multi-center PARTNER study assigned 699 high-risk patients with faulty aortic valves to standard surgery (351 patients) or TAVR (348 patients). At three years, all-cause mortality was nearly identical in both groups: 44.8 percent for standard surgery compared to 44.2 percent for TAVR. Cardiovascular mortality rates also were statistically indistinguishable at 30.2 percent for standard surgery and 30.1 percent for TAVR. Both groups displayed similar improvements in symptoms that have been maintained for three years.
"One of the concerns has been the durability of the valve, but there seems to be no structural deterioration thus far," said Vinod H. Thourani, MD, associate professor of cardiac surgery and co-director of the Structural Heart and Valve Center at Emory University School of Medicine in Atlanta. "It works as it's supposed to work, and hemodynamic performance is excellent past the three-year mark and comparable to surgical valve replacement."
With the much higher stroke rate reported for TAVR at 30 days, the other concern in this study has been whether a higher stroke risk would persist beyond that 30-day periprocedural window. None appeared at two or three years. TAVR stroke rates were 6 percent at one year, 7.7 percent at two years and 8.2 percent at three years, compared with 3.2 percent, 4.9 percent and 9.3 percent for standard surgery.
"After 30 days, TAVR patients don't have that many strokes," Dr. Thourani said. "At three years the surgery group's stroke rate has caught up with and slightly surpassed the TAVR rate but not to statistical significance."
Leaks around the valve were common soon after the procedure and were overwhelmingly higher in the TAVR group, and even mild aortic leakage is associated with a higher mortality rate after any valve replacement procedure, Dr. Thourani noted.
"In these first-generation transcatheter procedures, we have equivalent midterm outcomes between TAVR and the gold-standard surgical valve replacement in high-risk patients with severe aortic stenosis," Dr. Thourani said. "However, paravalvular leak continues to increase mortality at three years. Physicians should adopt innovative imaging technologies for more accurate sizing to help decrease these leak rates during TAVR."
The phase III study will follow patients for five years to assess durability of the TAVR device and longer-term outcomes.
###Edwards Lifesciences sponsored this clinical trial and provides funding to Emory University for the research. Dr. Thourani sits on the steering committee and the publications committee for the PARTNER study.
The ACC's Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention. Follow @ACCMediaCenter and #ACC13 for the latest news from the meeting.
The American College of Cardiology is a nonprofit medical society comprised of 43,000 physicians, surgeons, nurses, physician assistants, pharmacists and practice managers. The College is dedicated to transforming cardiovascular care, improving heart health and advancing quality improvement, patient-centered care, payment innovation and professionalism. The ACC also leads the formation of important cardiovascular health policy, standards and guidelines. It bestows credentials upon cardiovascular specialists, provides professional education, supports and disseminates cardiovascular research, and operates national registries to measure and promote quality care. For more information, visit cardiosource.org.
Dr. Thourani will be available to the media on Monday, March 11 at 9:40 a.m., in Moscone Center, South, Room 300.
Dr. Thourani will present the study "Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis" on Monday, March 11, at 8:00 a.m., in Moscone Center, South, Esplanade Ballroom.
Media Contacts
Beth Casteel
240-328-4549
bcasteel@acc.org
Dana Korsen
301-744-9636
acc@ecius.net
ACC.13 News Room
415-978-3511
Midterm stroke, death rates comparable for TAVR, standard surgery
Catheter-delivered aortic valve durable at 3 years
2013-03-12
ELSE PRESS RELEASES FROM THIS DATE:
Sleep discovery could lead to therapies that improve memory
2013-03-12
RIVERSIDE, Calif. — A team of sleep researchers led by UC Riverside psychologist Sara C. Mednick has confirmed the mechanism that enables the brain to consolidate memory and found that a commonly prescribed sleep aid enhances the process. Those discoveries could lead to new sleep therapies that will improve memory for aging adults and those with dementia, Alzheimer's and schizophrenia.
The groundbreaking research appears in a paper, "The Critical Role of Sleep Spindles in Hippocampal-Dependent Memory: A Pharmacology Study," published in the Journal of Neuroscience.
Earlier ...
Off-pump bypass better for high-risk patients
2013-03-12
SAN FRANCISCO (March 11, 2013) — Bypass surgery done without a heart-lung machine, known as off-pump, may provide better post-operative outcomes than on-pump bypass surgery for high-risk patients, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
In the first study to look specifically at on-pump versus off-pump bypass surgery among patients deemed to be at high operative risk, researchers examined the primary endpoint of patients' combined outcomes of all-cause death, stroke, heart attack or renal failure requiring ...
Exercise during gestation might affect future fertility
2013-03-12
Des Moines, IA - A short walk around the barn might improve the future fertility of Yorkshire gilts. According to research presented by Samantha Kaminski, a graduate student at North Dakota State University, swine fetuses showed significant ovarian development after their mothers exercised.
Kaminski and fellow researchers already knew that uterine blood flow could affect blood flow to the ovaries of developing fetuses. To further study the relationship between uterine blood flow and ovary development, Kaminski and fellow researchers designed an experiment to increase ...
Children who avoid scary situations likelier to have anxiety, Mayo Clinic research finds
2013-03-12
ROCHESTER, Minn. -- Children who avoid situations they find scary are likely to have anxiety a Mayo Clinic study of more than 800 children ages 7 to 18 found. The study published this month in Behavior Therapy presents a new method of measuring avoidance behavior in young children.
The researchers developed two eight-question surveys: the Children's Avoidance Measure Parent Report and the Children's Avoidance Measure Self Report. The questionnaires ask details about children's avoidance tendencies, for instance, in addressing parents, "When your child is scared or worried ...
Logging debris gives newly planted Douglas-fir forests a leg-up
2013-03-12
The downed limbs and other woody debris that are inevitable byproducts of timber harvest could be among the most important components of post-harvest landscapes, according to a new study led by the U.S. Forest Service's Pacific Northwest Research Station.
Researchers found that retaining moderate levels of logging debris, also known as "slash," helped to both directly and indirectly increase the growth rate of Douglas-fir seedlings replanted after harvest. The findings, which are among the first to speak to the benefits of second-growth logging debris, are published ...
Drug may improve outcomes after heart attack
2013-03-12
SAN FRANCISCO (March 10, 2013) — The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
The REMINDER (Reduction of heart failure morbidity in patients with acute ST-elevation myocardial infarction) trial was a randomized, double-blind trial of 1,012 patients who had a heart attack caused by a complete blockage of one of the heart's arteries. Patients had no signs or ...
Investigational drug reduces heart damage during angioplasty
2013-03-12
SAN FRANCISCO (March 10, 2013) — A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
More than 1 million coronary angioplasty procedures are performed in the United States each year, at a cost of more than $10 billion. Heart tissue can be damaged during angioplasty, often leading to additional procedures, poor outcomes and higher health care costs.
In this trial, researchers compared a single dose of ...
Clot-busting drug as effective as angioplasty
2013-03-12
SAN FRANCISCO (March 10, 2013) — A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
"Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology at University of Leuven, Belgium, and the study's lead investigator.
"It gives [clinicians] time to consider other options, such ...
Drug reduces chest pain in patients with diabetes
2013-03-12
SAN FRANCISCO (March 10, 2013) — A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both as first line therapy and as an add-on when symptoms are not relieved with other anti-anginal drugs, including beta-blockers, calcium channel ...
High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients
2013-03-12
SAN FRANCISCO (March 10, 2013) — Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit.
The TACT study tested the safety and effectiveness of ...
LAST 30 PRESS RELEASES:
People with sensitive personalities more likely to experience mental health problems
Want to improve early detection of diabetes? Look in the same households as those with abnormal blood sugar
Unveiling the gut-heart connection: The role of microbiota in heart failure
Breakthrough insights into tumor angiogenesis and endothelial cell origins
Unlocking the power of mitochondrial biogenesis to combat acute kidney injury
MIT study sheds light on graphite’s lifespan in nuclear reactors
The role of fucosylation in digestive diseases and cancer
Meet Allie, the AI-powered chess bot trained on data from 91 million games
Students’ image tool offers sharper signs, earlier detection in the lab or from space
UBC Okanagan study suggests fasting effects on the body are not the same for everyone
Children’s Hospital of Philadelphia and Children’s Hospital Colorado researchers conduct first prospective study of pediatric EoE patients and disease progression
Harnessing VR to prevent substance use relapse
The 8,000-year history recorded in Great Salt Lake sediments
To craft early tools, ancient human relatives transported stones over long distances 600,000 years earlier than previously thought
Human embryo implantation recorded in real time for the first time
70 years of data show adaptation reducing Europe’s flood losses
Recapitulating egg and sperm development in the dish
Study reveals benefits of traditional Himalayan crops
Scientist uncover hidden immune “hubs” that drive joint damage in rheumatoid arthritis
Congress of Neurological Surgeons releases first guidelines on the care of patients with functioning pituitary adenomas
New discovery could lower heart attack and stroke risk for people with type 2 diabetes
Tumor electrophysiology in precision tumor therapy
AI revolution in medicine: how large language models are transforming drug development
Hidden contamination in DNA extraction kits threatens accuracy of global zoonotic surveillance
Slicing and dictionaries: a new approach to medical big data
60 percent of the world’s land area is in a precarious state
Thousands of kids in mental health crisis are stuck for days in hospital emergency rooms, study finds
Prices and affordability of essential medicines in 72 low-, middle-, and high-income markets
Space mice babies
FastUKB: A revolutionary tool for simplifying UK Biobank data analysis
[Press-News.org] Midterm stroke, death rates comparable for TAVR, standard surgeryCatheter-delivered aortic valve durable at 3 years